8-K
filed October 23, 2025, 7:59 PM ET
ticker ENVB
CIK 0000890821
other material
confidence high
sentiment negative
materiality 0.85
Enveric Biosciences announces 1-for-12 reverse stock split to address Nasdaq bid-price deficiency
Enveric Biosciences, Inc.
- Reverse split effective 8:00 a.m. ET on October 28, 2025; shares outstanding to drop from 6,219,568 to ~518,297.
- Nasdaq notified company on Oct 22 of bid-price non-compliance (closing price <$1 for 30 days); no grace period due to prior reverse split.
- Company received $2.2M gross from warrant exercises in September to raise stockholders' equity above $2.5M minimum.
- Company intends to request a hearing to appeal delisting; no assurance of continued listing.
- Warrants issued in the inducement become exercisable only after stockholder approval per Nasdaq Rule 5635(d).
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-25-019095
- form_type
- 8-K
- ticker
- ENVB
- cik
- 0000890821
- company_name
- Enveric Biosciences, Inc.
- filed_at
- 2025-10-23T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:42.508951+00:00
- generated_at
- 2026-05-17T02:39:11.029664+00:00
- sec_items
- ["3.01", "3.03", "5.03", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-25-019095
- json_url
- https://secwatch.observer/filing/0001493152-25-019095.json
- markdown_url
- https://secwatch.observer/filing/0001493152-25-019095.md
- text_url
- https://secwatch.observer/filing/0001493152-25-019095.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/890821/000149315225019095/0001493152-25-019095-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/890821/000149315225019095/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
On October 23, 2025, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-12 reverse stock split of the shares of the Company’s Common Stock, either issued and outstanding or held by the Company as treasury stock, effective as of 8:00 a.m. (New York time) on October 28, 2025 (the “Reverse Stock Split”).
Comparable filing
On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.
Filing page
SEC filing
XXI
Tether International acquires SoftBank's stake in Twenty One Capital; board members resign
Twenty One Capital, Inc.
May 20, 2026, 8:49 AM ET
other_material
Items 1.02, 3.01, 5.02, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 8.01, 9.01
same event type: other_material
similar materiality
This filing
the “Company”) received a notice from The Nasdaq Stock
Market (the “Nasdaq”) indicating that it no longer met the continued listing requirements. Specifically, the Company’s
stockholders’ equity was below the minimum required stockholders’ equity of $2.5 million as stipulated by Nasdaq Listing
Rule 5550(b)(1) (“Rule 5550(b)(1)”). As
noted in the Original 8-K, the Company had until October 10, 2025 to provide Nasdaq with a specific plan to achieve and sustain compliance.
The Company submitted its plan to regain compliance on October 10, 2025. The Company is filing this Current Report on Form 8-
Comparable filing
o independent directors, the minimum number required during the transition period
for compliance with Section 303A.07(a) of the NYSE Listed Company Manual, as provided in Section 303A.00 of the NYSE Listed Company Manual
Filing page
SEC filing
SUJA
Suja Life completes IPO of 8.9M shares at $21/share; closes May 8, 2026
SUJA LIFE, INC.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 3.03, 5.03, 5.02, 9.01
same fact type: governance_change
same SEC item: 3.03, 5.03, 9.01
same event type: other_material
similar materiality
This filing
On October 23, 2025, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-12 reverse stock split of the shares of the Company’s Common Stock, either issued and outstanding or held by the Company as treasury stock, effective as of 8:00 a.m. (New York time) on October 28, 2025 (the “Reverse Stock Split”).
Comparable filing
On May 7, 2026, the Company filed an amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware
Filing page
SEC filing
ADT
Apollo sells all 102M ADT shares; ADT repurchases 29.1M shares in $1.5B plan
ADT Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 8.01, 9.01
same event type: other_material
similar materiality
This filing
On October 23, 2025, the Company filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-12 reverse stock split of the shares of the Company’s Common Stock, either issued and outstanding or held by the Company as treasury stock, effective as of 8:00 a.m. (New York time) on October 28, 2025 (the “Reverse Stock Split”).
Comparable filing
On May 8, 2026, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, dated as of September 15, 2023 (as amended, the “ Bylaws ”), to remove references related to Apollo and the Amended and Restated Stockholders Agreement, dated December 14, 2018, between the Company, Prime Security Services TopCo Parent, L.P., and the Co-Investors.
Filing page
SEC filing
ADTX
Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11
Aditxt, Inc.
May 29, 2026, 4:21 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
the “Company”) received a notice from The Nasdaq Stock
Market (the “Nasdaq”) indicating that it no longer met the continued listing requirements. Specifically, the Company’s
stockholders’ equity was below the minimum required stockholders’ equity of $2.5 million as stipulated by Nasdaq Listing
Rule 5550(b)(1) (“Rule 5550(b)(1)”). As
noted in the Original 8-K, the Company had until October 10, 2025 to provide Nasdaq with a specific plan to achieve and sustain compliance.
The Company submitted its plan to regain compliance on October 10, 2025. The Company is filing this Current Report on Form 8-
Comparable filing
May 27, 2026, Aditxt, Inc. (the “Company”)
received a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market
LLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s
Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum
stockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)
(the “Stockholders’ Equity Requirement”). The Letter further
Filing page
SEC filing
LIMN
Liminatus Pharma receives Nasdaq delisting notice; appeals filed
Liminatus Pharma, Inc.
May 27, 2026, 4:30 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
the “Company”) received a notice from The Nasdaq Stock
Market (the “Nasdaq”) indicating that it no longer met the continued listing requirements. Specifically, the Company’s
stockholders’ equity was below the minimum required stockholders’ equity of $2.5 million as stipulated by Nasdaq Listing
Rule 5550(b)(1) (“Rule 5550(b)(1)”). As
noted in the Original 8-K, the Company had until October 10, 2025 to provide Nasdaq with a specific plan to achieve and sustain compliance.
The Company submitted its plan to regain compliance on October 10, 2025. The Company is filing this Current Report on Form 8-
Comparable filing
May 20, 2026, the Company received a notice
from Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will
be delisted from The Nasdaq Global Mark
Filing page
SEC filing
AGAE
AIFA gets Nasdaq delisting notice for late filings; later files FY 2025 10-K
Allied Gaming & Entertainment Inc.
May 21, 2026, 9:40 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
the “Company”) received a notice from The Nasdaq Stock
Market (the “Nasdaq”) indicating that it no longer met the continued listing requirements. Specifically, the Company’s
stockholders’ equity was below the minimum required stockholders’ equity of $2.5 million as stipulated by Nasdaq Listing
Rule 5550(b)(1) (“Rule 5550(b)(1)”). As
noted in the Original 8-K, the Company had until October 10, 2025 to provide Nasdaq with a specific plan to achieve and sustain compliance.
The Company submitted its plan to regain compliance on October 10, 2025. The Company is filing this Current Report on Form 8-
Comparable filing
May 19, 2026, All In FutureTech Alliance,
Inc. (formerly known as Allied Gaming & Entertainment Inc., the “Company”) received a deficiency letter (the “Letter”)
from the Listing Qualifications Department (the “Staff”) of
Filing page
SEC filing
PMI
Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices
Picard Medical, Inc.
May 21, 2026, 4:15 PM ET
other_material
Items 2.02, 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
same event type: other_material
similar materiality
This filing
the “Company”) received a notice from The Nasdaq Stock
Market (the “Nasdaq”) indicating that it no longer met the continued listing requirements. Specifically, the Company’s
stockholders’ equity was below the minimum required stockholders’ equity of $2.5 million as stipulated by Nasdaq Listing
Rule 5550(b)(1) (“Rule 5550(b)(1)”). As
noted in the Original 8-K, the Company had until October 10, 2025 to provide Nasdaq with a specific plan to achieve and sustain compliance.
The Company submitted its plan to regain compliance on October 10, 2025. The Company is filing this Current Report on Form 8-
Comparable filing
reviously disclosed, on May
8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together
with the May 15 Notice, the “ Notices ”). In connection with the
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.